Table 2.
Factors associated with polypharmacy at the end of the observation period, multiple logistic regression model.
| Odds ratio | 95% CI | P-value | |
|---|---|---|---|
| Sex: Male | 2.63 | 0.91–7.56 | 0.073 |
| Age (years) | |||
| <40 (n = 144) | Reference | ||
| 40–49 (n = 387) | 2.71 | 1.02–7.22 | 0.046 |
| 50–59 (n = 301) | 2.96 | 1.10–7.99 | 0.032 |
| ≥ 60 (n = 52) | 4.43 | 1.31–15.0 | 0.017 |
| Number of consultations in 3 years | |||
| 1–10 (n = 207) | Reference | ||
| 11–20 (n = 174) | 5.56 | 1.56–20.0 | 0.008 |
| 21–30 (n = 196) | 9.63 | 2.82–32.8 | <0.001 |
| ≥30 (n = 307) | 11.6 | 3.52–38.5 | <0.001 |
| BMI (kg/m2) ≥ 25 | 1.71 | 1.04–2.80 | 0.033 |
| SU drug | 1.32 | 0.78–2.25 | 0.309 |
BMI, body mass index; SU, sulfonylurea.